Arbutus Biopharma (ABUS) Current Deferred Tax Assets: 2010-2014
Historic Current Deferred Tax Assets for Arbutus Biopharma (ABUS) over the last 3 years, with Jun 2014 value amounting to $57,000.
- Arbutus Biopharma's Current Deferred Tax Assets fell 80.99% to $57,000 in Q2 2014 from the same period last year, while for Jun 2014 it was $57,000, marking a year-over-year decrease of 80.99%. This contributed to the annual value of $173,000 for FY2013, which is 52.04% down from last year.
- Latest data reveals that Arbutus Biopharma reported Current Deferred Tax Assets of $57,000 as of Q2 2014, which was down 48.65% from $111,000 recorded in Q1 2014.
- Arbutus Biopharma's 5-year Current Deferred Tax Assets high stood at $549,938 for Q4 2010, and its period low was -$226,999 during Q4 2011.
- In the last 3 years, Arbutus Biopharma's Current Deferred Tax Assets had a median value of $209,023 in 2013 and averaged $218,571.
- Its Current Deferred Tax Assets has fluctuated over the past 5 years, first tumbled by 141.28% in 2011, then skyrocketed by 2,466.95% in 2012.
- Arbutus Biopharma's Current Deferred Tax Assets (Quarterly) stood at $549,938 in 2010, then tumbled by 141.28% to -$226,999 in 2011, then skyrocketed by 258.91% to $360,720 in 2012, then tumbled by 52.04% to $173,000 in 2013, then plummeted by 80.99% to $57,000 in 2014.
- Its last three reported values are $57,000 in Q2 2014, $111,000 for Q1 2014, and $173,000 during Q4 2013.